[1] |
Rentscher KE, Zhou X, Small BJ, et al. Loneliness and mental health during the COVID-19 pandemic in older breast cancer survivors and noncancer controls[J]. Cancer,2021, 127(19):3671-3679.
|
[2] |
Chavez-MacGregor M, Lei X, Zhao H,et al. Evaluation of COVID-19 mortality and adverse outcomes in US patients with or without cancer[J]. JAMA Oncol, 2022,8(1):69-78.
|
[3] |
Fan Y, Li X, Zhang L, et al. SARS-CoV-2 Omicron variant: recent progress and future perspectives[J]. Signal Transduct Target Ther, 2022, 7(1):141.
|
[4] |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3):209-249.
|
[5] |
Arnold M, Morgan E, Rumgay H, et al. Current and future burden of breast cancer: Global statistics for 2020 and 2040[J]. Breast, 2022, 66:15-23.
|
[6] |
Cao W, Chen HD, Yu YW, et al. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020[J]. Chin Med J (Engl), 2021, 134(7):783-791.
|
[7] |
Li J, Wang H, Geng C, et al. Suboptimal declines and delays in early breast cancer treatment after COVID-19 quarantine restrictions in China: a national survey of 8397 patients in the first quarter of 2020[J]. EClinicalMedicine,2020, 26:100 503.
|
[8] |
Yang J, Fu Z, Du L, et al. Time to surgery in patients with breast cancer during the COVID-19 pandemic[J]. Br J Surg, 2020, 107(10):e419-e421.
|
[9] |
Habbous S, Tai X, Beca JM, et al. Comparison of use of neoadjuvant systemic treatment for breast cancer and short-term outcomes before vs during the COVID-19 era in Ontario, Canada[J]. JAMA Netw Open, 2022, 5(8):e2 225 118.
|
[10] |
国家卫生健康委员会办公厅,国家中医药管理局办公室.新型冠状病毒肺炎诊疗方案(试行第九版)[EB/OL].[2022-03-14].
URL
|
[11] |
Riley J, Gleghorn D, Doudican BC, et al. Psychological assessment of individuals with Mal de Débarquement Syndrome[J]. J Neurol, 2022, 269(4):2149-2161.
|
[12] |
Forster M, Wuerstlein R, Koenig A, et al. COVID-19 vaccination in patients with breast cancer and gynecological malignancies: A German perspective[J]. Breast, 2021, 60:214-222.
|
[13] |
邱菊,罗凤,吴凯南,等.乳腺癌患者新型冠状病毒肺炎疫苗接种及疫苗犹豫现状分析[J].现代医药卫生,2022,38(5):729-733.
|
[14] |
国务院应对新型冠状病毒肺炎疫情联防联控机制综合组.关于进一步优化落实新冠肺炎疫情防控措施的通知[联防联控机制综发(2022)113号] [EB/OL].[2022-12-07].
URL
|
[15] |
Dai M, Liu D, Liu M, et al. Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak[J]. Cancer Discov, 2020,10(6):783-791.
|
[16] |
Song Q, Bates B, Shao YR, et al. Risk and outcome of breakthrough COVID-19 infections in vaccinated patients with cancer: real-world evidence from the national COVID cohort collaborative[J].J Clin Oncol, 2022, 40(13):1414-1427.
|
[17] |
邹容容,张影,袁静. 2019新型冠状病毒奥密克戎变异株感染者38例的临床特征分析[J]. 中华传染病杂志,2022,40(5): 293-295.
|
[18] |
吕莹,袁伟,施冬玲,等.2019新型冠状病毒奥密克戎变异株感染者的临床特征分析[J].中华传染病杂志,2022,40(5): 257-263.
|
[19] |
刘莹,李美瑜,李锋,等.广州市输入性2019新型冠状病毒奥密克戎与德尔塔变异株感染者的临床特征分析[J].中华传染病杂志,2022,40(10):584-590.
|
[20] |
Rüthrich MM, Giessen-Jung C, Borgmann S, et al. COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry[J]. Ann Hematol, 2021,100(2):383-393.
|
[21] |
俞荣,马欢欢,邓小博,等.新型冠状病毒感染对肿瘤治疗的影响[J].中国肿瘤临床,2022, 49(8):411-416.
|